PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.48%
Positive revenue growth while MTDR is negative. John Neff might see a notable competitive edge here.
32.96%
Positive gross profit growth while MTDR is negative. John Neff would see a clear operational edge over the competitor.
-5.94%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-5.94%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-31.82%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-32.50%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-31.93%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.84%
OCF growth under 50% of MTDR's 119.33%. Michael Burry might suspect questionable revenue recognition or rising costs.
198.09%
FCF growth above 1.5x MTDR's 96.41%. David Dodd would verify if the firm’s strategic investments yield superior returns.
2.64%
10Y revenue/share CAGR under 50% of MTDR's 86.22%. Michael Burry would suspect a lasting competitive disadvantage.
-34.07%
Negative 5Y CAGR while MTDR stands at 86.22%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-77.73%
Negative 3Y CAGR while MTDR stands at 86.22%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-11.21%
Negative 5Y OCF/share CAGR while MTDR is at 214.78%. Joel Greenblatt would question the firm’s operational model or cost structure.
-55.45%
Negative 3Y OCF/share CAGR while MTDR stands at 214.78%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-52.11%
Negative 10Y net income/share CAGR while MTDR is at 137.87%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-90.29%
Negative 5Y net income/share CAGR while MTDR is 137.87%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-96.56%
Negative 3Y CAGR while MTDR is 137.87%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
357.84%
Equity/share CAGR of 357.84% while MTDR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-1.47%
Negative 5Y equity/share growth while MTDR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-28.54%
Negative 3Y equity/share growth while MTDR is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
101.92%
Stable or rising mid-term dividends while MTDR is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-49.90%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-5.19%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-50.00%
Inventory is declining while MTDR stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.60%
Negative asset growth while MTDR invests at 5.08%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.42%
We have a declining book value while MTDR shows 2.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.88%
Debt growth of 1.88% while MTDR is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-35.82%
We cut SG&A while MTDR invests at 19.06%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.